Filing Flows › Traws Pharma (TRAW) › Stock forecast & fair value
Traws Pharma (TRAW) stock forecast and price target
Traws Pharma (TRAW) trades at $0.22. One analyst's price target is $1.00 (+351%).
Traws Pharma's latest quarter
Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for TRAW stock?
One analyst's 12-month target is $1.00, +351% from $0.22. The average rating is none.
Does Traws Pharma usually beat earnings estimates?
It beat the consensus EPS estimate in 67% of the quarters on record.
Is TRAW stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.